311 related articles for article (PubMed ID: 35563557)
1. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Pentimalli F; Giordano A; Calleja-Agius J
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563557
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
3. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer stem cells: opportunities and challenges.
Chhabra R
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer.
Organista-Nava J; Gómez-Gómez Y; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Oncol Lett; 2019 Jul; 18(1):7-14. PubMed ID: 31289465
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathway.
Wu L; Han L; Zhou C; Wei W; Chen X; Yi H; Wu X; Bai X; Guo S; Yu Y; Liang L; Wang W
FEBS J; 2017 Sep; 284(18):3000-3017. PubMed ID: 28703907
[TBL] [Abstract][Full Text] [Related]
7. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
[TBL] [Abstract][Full Text] [Related]
8. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
Fahmi MN; Hertapanndika IN; Kusuma F
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
[TBL] [Abstract][Full Text] [Related]
10. SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.
Ye S; Ding YF; Jia WH; Liu XL; Feng JY; Zhu Q; Cai SL; Yang YS; Lu QY; Huang XT; Yang JS; Jia SN; Ding GP; Wang YH; Zhou JJ; Chen YD; Yang WJ
Cancer Res; 2019 Sep; 79(18):4729-4743. PubMed ID: 31308046
[TBL] [Abstract][Full Text] [Related]
11. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
13. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
[TBL] [Abstract][Full Text] [Related]
14. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
Nayak A; Das S; Nayak D; Sethy C; Narayan S; Kundu CN
Cell Oncol (Dordr); 2019 Apr; 42(2):157-171. PubMed ID: 30603978
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cervical Cancer Stem Cells by Phytochemicals.
Tripathi T; Yadav J; Janjua D; Chaudhary A; Joshi U; Senrung A; Chhokar A; Aggarwal N; Bharti AC
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38288813
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
17. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
18. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway.
Dong Z; Yu C; Rezhiya K; Gulijiahan A; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3711-3719. PubMed ID: 31522559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
